Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis. [electronic resource]
- The British journal of dermatology 06 2018
- 1297-1307 p. digital
Absenteeism Activities of Daily Living Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Dermatologic Agents--therapeutic use Double-Blind Method Efficiency Employment Female Humans Latent Class Analysis Male Middle Aged Pain--prevention & control Pruritus--prevention & control Psoriasis--drug therapy Quality of Life Severity of Illness Index Treatment Outcome Ustekinumab--therapeutic use